Daiichi Sankyo Announces the Presentation of New Data on LIXIANA® (edoxaban) to be Presented at ESC Congress 2019
Munich (ots/PRNewswire) - Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced clinical results for edoxaban (known by the brand name LIXIANA®) will be featured as a late-breaking oral presentation and as poster presentations at ESC Congress 2019, taking place from 31 August-04 September in Paris, France.
- Data presentations from ENTRUST-AF PCI and ETNA-AF add to the growing body of scientific evidence from the Edoxaban Clinical Research Programme
- First-time presentation of ENTRUST-AF PCI clincial!-->…